Literature DB >> 11118430

Mechanism of human group V phospholipase A2 (PLA2)-induced leukotriene biosynthesis in human neutrophils. A potential role of heparan sulfate binding in PLA2 internalization and degradation.

K P Kim1, J D Rafter, L Bittova, S K Han, Y Snitko, N M Munoz, A R Leff, W Cho.   

Abstract

Human group V phospholipase A(2) (hVPLA(2)) has been shown to have high activity to elicit leukotriene production in human neutrophils (Han, S. K., Kim, K. P., Koduri, R., Bittova, L., Munoz, N. M., Leff, A. R., Wilton, D. C., Gelb, M. H., and Cho, W. (1999) J. Biol. Chem. 274, 11881-11888). To determine the mechanism by which hVPLA(2) interacts with cell membranes to induce leukotriene formation, we mutated surface cationic residues and a catalytic residue of hVPLA(2) and measured the interactions of mutants with model membranes, immobilized heparin, and human neutrophils. These studies showed that cationic residues, Lys(7), Lys(11), and Arg(34), constitute a part of the interfacial binding surface of hVPLA(2), which accounts for its moderate preference for anionic membranes. Additionally, hVPLA(2) binds heparin with high affinity and has a well defined heparin-binding site. The site is composed of Arg(100), Lys(101), Lys(107), Arg(108), and Arg(111), and is spatially distinct from its interfacial binding surface. Importantly, the activities of the mutants to hydrolyze cell membrane phospholipids and induce leukotriene biosynthesis, when enzymes were added exogenously to neutrophils, correlated with their activities on phosphatidylcholine membranes but not with their affinities for anionic membranes and heparin. These results indicate that hVPLA(2) acts directly on the outer plasma membranes of neutrophils to release fatty acids and lysophospholipids. Further studies suggest that products of hVPLA(2) hydrolysis trigger the cellular leukotriene production by activating cellular enzymes involved in leukotriene formation. Finally, the temporal and spatial resolution of exogenously added hVPLA(2) and mutants suggests that binding to cell surface heparan sulfate proteoglycans is important for the internalization and clearance of cell surface-bound hVPLA(2).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118430     DOI: 10.1074/jbc.M004604200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Phospholipids of tumor extracellular vesicles stratify gefitinib-resistant nonsmall cell lung cancer cells from gefitinib-sensitive cells.

Authors:  Jae Hun Jung; Min Young Lee; Do-Young Choi; Jae Won Lee; Sungyong You; Kye Young Lee; Jayoung Kim; Kwang Pyo Kim
Journal:  Proteomics       Date:  2015-01-16       Impact factor: 3.984

2.  Epigenetic control of group V phospholipase A2 expression in human malignant cells.

Authors:  Mario Menschikowski; Albert Hagelgans; Brit Nacke; Carsten Jandeck; Olga A Mareninova; Liana Asatryan; Gabriele Siegert
Journal:  Tumour Biol       Date:  2015-12-29

3.  The Role of Phospholipase A(2)-derived Mediators in Obesity.

Authors:  Marcia J Abbott; Tianyi Tang; Hei Sook Sul
Journal:  Drug Discov Today Dis Mech       Date:  2010

4.  Biallelic mutations in PLA2G5, encoding group V phospholipase A2, cause benign fleck retina.

Authors:  Panagiotis I Sergouniotis; Alice E Davidson; Donna S Mackay; Eva Lenassi; Zheng Li; Anthony G Robson; Xu Yang; Jaimie Hoh Kam; Timothy W Isaacs; Graham E Holder; Glen Jeffery; Jonathan A Beck; Anthony T Moore; Vincent Plagnol; Andrew R Webster
Journal:  Am J Hum Genet       Date:  2011-12-01       Impact factor: 11.025

5.  Degradation of group V secretory phospholipase A2 in lung endothelium is mediated by autophagy.

Authors:  Lucille N Meliton; Xiangdong Zhu; Mary Brown; Yulia Epshtein; Takeshi Kawasaki; Eleftheria Letsiou; Steven M Dudek
Journal:  Microvasc Res       Date:  2019-11-13       Impact factor: 3.514

6.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

Review 7.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

8.  Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice.

Authors:  Nilda M Muñoz; Angelo Y Meliton; Lucille N Meliton; Steven M Dudek; Alan R Leff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-13       Impact factor: 5.464

Review 9.  Role of secretory phospholipases in atherogenesis.

Authors:  Ann-Cathrine Jönsson-Rylander; Sofia Lundin; Birgitta Rosengren; Camilla Pettersson; Eva Hurt-Camejo
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

10.  Effects of cholesterol on physical properties of human erythrocyte membranes: impact on susceptibility to hydrolysis by secretory phospholipase A2.

Authors:  Anne L Heiner; Elizabeth Gibbons; Jeremy L Fairbourn; Laurie J Gonzalez; Chisako O McLemore; Taylor J Brueseke; Allan M Judd; John D Bell
Journal:  Biophys J       Date:  2008-01-11       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.